141 related articles for article (PubMed ID: 35019778)
1. Clinical and Microbiological Characteristics of Mycobacterium kansasii Pulmonary Infections in China.
Guo Y; Cao Y; Liu H; Yang J; Wang W; Wang B; Li M; Yu F
Microbiol Spectr; 2022 Feb; 10(1):e0147521. PubMed ID: 35019778
[TBL] [Abstract][Full Text] [Related]
2. Drug Susceptibility Profiling and Genetic Determinants of Drug Resistance in Mycobacterium kansasii.
Bakuła Z; Modrzejewska M; Pennings L; Proboszcz M; Safianowska A; Bielecki J; van Ingen J; Jagielski T
Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29437627
[TBL] [Abstract][Full Text] [Related]
3. Mycobacterium kansasii: antibiotic susceptibility and PCR-restriction analysis of clinical isolates.
da Silva Telles MA; Chimara E; Ferrazoli L; Riley LW
J Med Microbiol; 2005 Oct; 54(Pt 10):975-979. PubMed ID: 16157553
[TBL] [Abstract][Full Text] [Related]
4. Drug susceptibility profile of Mycobacterium kansasii clinical isolates from Brazil.
de Carvalho LD; de Queiroz Mello FC; Redner P; Campos CED; de Souza Caldas PC; da Silva Lourenço MC; Ramos JP
J Glob Antimicrob Resist; 2019 Dec; 19():228-230. PubMed ID: 31100506
[TBL] [Abstract][Full Text] [Related]
5. Drug resistance profile of Mycobacterium kansasii clinical isolates before and after 2-month empirical antimycobacterial treatment.
Zhang Y; Yu C; Jiang Y; Zheng X; Wang L; Li J; Shen X; Xu B
Clin Microbiol Infect; 2023 Mar; 29(3):353-359. PubMed ID: 36209990
[TBL] [Abstract][Full Text] [Related]
6. Drug susceptibility profiling and genetic determinants of drug resistance in Mycobacterium simiae isolates obtained from regional tuberculosis reference laboratories of Iran.
Daneshfar S; Khosravi AD; Hashemzadeh M
PLoS One; 2022; 17(8):e0267320. PubMed ID: 35960778
[TBL] [Abstract][Full Text] [Related]
7. Comparative in vitro activities of linezolid, telithromycin, clarithromycin, levofloxacin, moxifloxacin, and four conventional antimycobacterial drugs against Mycobacterium kansasii.
Alcaide F; Calatayud L; Santín M; Martín R
Antimicrob Agents Chemother; 2004 Dec; 48(12):4562-5. PubMed ID: 15561826
[TBL] [Abstract][Full Text] [Related]
8. Rifampin resistance in Mycobacterium kansasii is associated with rpoB mutations.
Klein JL; Brown TJ; French GL
Antimicrob Agents Chemother; 2001 Nov; 45(11):3056-8. PubMed ID: 11600355
[TBL] [Abstract][Full Text] [Related]
9. Short communication: subtyping of Mycobacterium kansasii by PCR-restriction enzyme analysis of the hsp65 gene.
Bakuła Z; Safianowska A; Nowacka-Mazurek M; Bielecki J; Jagielski T
Biomed Res Int; 2013; 2013():178725. PubMed ID: 24455675
[TBL] [Abstract][Full Text] [Related]
10. AIDS-related Mycobacterium kansasii infection with initial resistance to clarithromycin.
Burman WJ; Stone BL; Brown BA; Wallace RJ; Böttger EC
Diagn Microbiol Infect Dis; 1998 Jun; 31(2):369-71. PubMed ID: 9635911
[TBL] [Abstract][Full Text] [Related]
11. The beginning of the rpoB gene in addition to the rifampin resistance determination region might be needed for identifying rifampin/rifabutin cross-resistance in multidrug-resistant Mycobacterium tuberculosis isolates from Southern China.
Tan Y; Hu Z; Zhao Y; Cai X; Luo C; Zou C; Liu X
J Clin Microbiol; 2012 Jan; 50(1):81-5. PubMed ID: 22075601
[TBL] [Abstract][Full Text] [Related]
12. Mycobacterium kansasii.
Johnston JC; Chiang L; Elwood K
Microbiol Spectr; 2017 Jan; 5(1):. PubMed ID: 28185617
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary Mycobacterium kansasii infection in Israel, 1999-2004: clinical features, drug susceptibility, and outcome.
Shitrit D; Baum GL; Priess R; Lavy A; Shitrit AB; Raz M; Shlomi D; Daniele B; Kramer MR
Chest; 2006 Mar; 129(3):771-6. PubMed ID: 16537880
[TBL] [Abstract][Full Text] [Related]
14. Detection of Mycobacterium kansasii using a combination of loop-mediated isothermal amplification (LAMP) and lateral flow biosensors.
Chen C; Lu J; Long B; Rao Z; Gao Y; Wang W; Gao W; Yang J; Zhang S
Int Microbiol; 2021 Jan; 24(1):75-82. PubMed ID: 32880033
[TBL] [Abstract][Full Text] [Related]
15. Strain variation amongst clinical and potable water isolates of M. kansasii using automated repetitive unit PCR.
Thomson R; Tolson C; Huygens F; Hargreaves M
Int J Med Microbiol; 2014 May; 304(3-4):484-9. PubMed ID: 24636860
[TBL] [Abstract][Full Text] [Related]
16. False-positive Gen-Probe direct Mycobacterium tuberculosis amplification test results for patients with pulmonary M. kansasii and M. avium infections.
Jorgensen JH; Salinas JR; Paxson R; Magnon K; Patterson JE; Patterson TF
J Clin Microbiol; 1999 Jan; 37(1):175-8. PubMed ID: 9854086
[TBL] [Abstract][Full Text] [Related]
17. Drug resistance profiles and related gene mutations in slow-growing non-tuberculous mycobacteria isolated in regional tuberculosis reference laboratories of Iran: a three year cross-sectional study.
Akrami S; Dokht Khosravi A; Hashemzadeh M
Pathog Glob Health; 2023 Feb; 117(1):52-62. PubMed ID: 35261334
[TBL] [Abstract][Full Text] [Related]
18. Molecular characterization of Mycobacterium kansasii isolates in the State of São Paulo between 1995-1998.
Chimara E; Giampaglia CM; Martins MC; Telles MA; Ueki SY; Ferrazoli L
Mem Inst Oswaldo Cruz; 2004 Nov; 99(7):739-43. PubMed ID: 15654431
[TBL] [Abstract][Full Text] [Related]
19. [Frequently Isolated Slow Growing Nontuberculous Mycobacteria from Pulmonary Samples and Evaluation of Drug Susceptibility Testing Results in a Referral Hospital in Turkey].
Ceyhan İ; Özkara Ş; Güler MZ; Dulkar G; Altınsoy R; Vezir S
Mikrobiyol Bul; 2019 Jul; 53(3):330-335. PubMed ID: 31414634
[TBL] [Abstract][Full Text] [Related]
20. Molecular characterisation of clinical and environmental isolates of Mycobacterium kansasii isolates from South African gold mines.
Kwenda G; Churchyard GJ; Thorrold C; Heron I; Stevenson K; Duse AG; Marais E
J Water Health; 2015 Mar; 13(1):190-202. PubMed ID: 25719478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
